FY26-RFQ-OCME-BPA for Postmortem Testing-Open Market

The District of Columbia Chief Medical Examiner’s Office is issuing an open‑market Blanket Purchase Agreement (BPA) to acquire postmortem clinical laboratory testing services. The BPA will cover non‑drug screening tests (e.g., toxicology, histology, microbiology) required for forensic autopsies. Vendors must be capable of delivering accurate, timely results to support the OCME’s investigative and judicial responsibilities. • Commodity: 9,485,583 – Clinical Laboratory Tests, Non‑Drug Screening • Open market competition – no single‑source restriction • BPA framework allows multiple task orders over the contract period • Services to be performed at the OCME’s designated work sites (location not specified) • Award will be based on pricing and technical capability per RFQ evaluation criteria